Grace Gallagher

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “The landscape of use of NCCN-guideline chemotherapy regimens in stage I-IIIA breast cancer in an integrated healthcare delivery system”.

The landscape of use of NCCN-guideline chemotherapy regimens in stage I-IIIA breast cancer in an integrated healthcare delivery system

Breast Cancer Research and Treatment(2024)10.1007/s10549-024-07433-4

N/A

0.359DataRank · unranked

7 citations

Kelli O’Connell, Sonia Persaud, Victoria Blinder, Rachael Burganowski, Isaac J. Ergas +18 more

Trends in chemotherapy use for early-stage breast cancer from 2006 to 2019

Breast Cancer Research(2024)10.1186/s13058-024-01822-9

N/A

0DataRank · unranked

11 citations

Kelli O’Connell, Isaac J. Ergas, Marilyn J. Foley, Grace Gallagher, Jennifer J. Griggs +17 more

Patient characteristics associated with delayed time to adjuvant chemotherapy among women treated for stage I–IIIA breast cancer

International Journal of Cancer(2024)10.1002/ijc.35053

N/A

0DataRank · unranked

4 citations

Kelli O’Connell, Sonia Persaud, Victoria Blinder, Rachael Burganowski, Isaac J. Ergas +19 more

Trends in financial payments from industry to US cancer centers, 2014-2021

JNCI Cancer Spectrum(2024)10.1093/jncics/pkae015

N/A

0DataRank · unranked

3 citations

Meredith S. Brown, Sonia Persaud, Grace Gallagher, Niti U. Trivedi, Peter B. Bach +2 more

Patient Characteristics Associated with Intended Nonguideline Chemotherapy in Women with Stage I to IIIA Breast Cancer

Cancer Epidemiology Biomarkers & Prevention(2024)10.1158/1055-9965.epi-24-0360

N/A

0DataRank · unranked

2 citations

Kelli O’Connell, Sonia Persaud, Victoria Blinder, Rachael P. Burganowski-Doud, Isaac J. Ergas +18 more

Provider and facility factors in relation to receipt of dose-reduced chemotherapy among patients with breast cancer.

JCO Oncology Practice(2024)10.1200/op.2024.20.10_suppl.310

N/A

0DataRank · unranked

0 citations

Kelli O’Connell, Jenna Bhimani, Victoria Blinder, Rachael Doud, Grace Gallagher +15 more

GWAS meta-analysis identifies five susceptibility loci for endometrial cancer

EBioMedicine(2025)10.1016/j.ebiom.2025.105830

N/A

0DataRank · unranked

3 citations

Xue Min Wang, Triin Laisk, Ying Zheng, Nathan Ingold, Daffodil M. Canson +69 more

Hypertension and Risk of Endometrial Cancer: A Pooled Analysis in the Epidemiology of Endometrial Cancer Consortium (E2C2)

Cancer Epidemiology Biomarkers & Prevention(2024)10.1158/1055-9965.epi-23-1444

N/A

0DataRank · unranked

18 citations

Noah C. Peeri, Immaculata De Vivo, Leo J. Schouten, Xiao‐Ou Shu, Michele L. Coté +50 more

Associations between age and chemotherapy dose reductions in women with stage I-IIIA breast cancer

JNCI Journal of the National Cancer Institute(2025)10.1093/jnci/djaf314

N/A

0DataRank · unranked

1 citations

Kelli O’Connell, Jenna Bhimani, Grace Gallagher, Victoria Blinder, Rachael Doud +19 more